Mesa, Ruben A.
Su, Yun
Woolfson, Adrien
Prchal, Josef T.
Turnbull, Kathleen
Jabbour, Elias
Scherber, Robyn
Shields, Alan L.
Krohe, Meaghan http://orcid.org/0000-0003-4306-6870
Ojo, Funke
Pompilus, Farrah
Cappelleri, Joseph C.
Harrison, Claire
Funding for this research was provided by:
Pfizer (PI8361A)
Article History
Received: 14 January 2019
Accepted: 14 March 2019
First Online: 11 April 2019
Ethics approval and consent to participate
: Ethical review and approval of all documents related to both concept elicitation and cognitive debriefing patient interviews was provided by a centralized independent review board, Copernicus Group IRB. All patient participants provided signed informed consent and the Health Insurance Portability and Accountability Act Authorization prior to any data being collected.
: Not applicable.
: AW, YS and JCC are employees and stockholders of Pfizer Inc., which funded the study. ALS, MK, FO, and FP are employees of Adelphi Values, paid consultants to Pfizer in connection with the development of this manuscript. RAM, JTP, KT, EJ, RS, and CH have no conflict of interest to disclose.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.